| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.002 |